Skip to main content
. 2015 Dec;12(4):401–408. doi: 10.7497/j.issn.2095-3941.2015.0013

Figure 4.

Figure 4

(A) NF-κB Inactivation is enhanced by CAL-101/Bortezomib combination. (B) Combined treatment induced marked downregulation of p-AKT in MCL cells. (C) Caspase-3 was up-regulated after combined treatment in MCL cell lines.